NEW YORK, Oct. 26, 2016 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Wells Fargo & Company securities (NYSE:WFC) from February 26, 2014 through September 15, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Wells Fargo investors under the federal securities laws.
To join the Wells Fargo class action, go to the firm’s website at http://rosenlegal.com/cases-957.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email [email protected] or [email protected] for more information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants issued false and misleading statements to investors that Wells Fargo’s cross-selling efforts to retail customers were the product of a carefully designed system that resulted in Wells Fargo illegally, through forgery and other electronic means, opening millions of deposit and credit card accounts for customers without their knowledge in an effort to generate fee income for Wells Fargo and compensation rewards for Wells Fargo employees, including defendants. Wells Fargo also failed to disclose that an ongoing internal investigation had determined by the beginning of the Class Period that employees in the Community Banking segment had engaged in a wide ranging scheme to inflate Wells Fargo’s financial performance figures by opening millions of unauthorized deposit and credit card accounts, ultimately resulting in more than 5,000 employee terminations. As a result, defendants’ statements about Wells Fargo’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 25, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-957.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 



